Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has got regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment for COVID-19.
from Times of India https://ift.tt/3e2G0ao
No comments:
Post a Comment